Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Edwards Lifesciences Corporation, Agilent Technologies or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Edwards Lifesciences Corporation, Agilent Technologies and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Edwards Lifesciences Corporation, Agilent Technologies and Inc.

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Latest Health Care Equipment & Supplies and Edwards Lifesciences Corporation, Agilent Technologies, Inc. Stock News

As of September 1, 2026, Edwards Lifesciences Corporation had a $52.3 billion market capitalization, compared to the Health Care Equipment & Supplies median of $405.9 million. Edwards Lifesciences Corporation’s stock is up 6.5% in 2026, in the previous five trading days and up 11.56% in the past year.

Currently, Edwards Lifesciences Corporation’s price-earnings ratio is 54.1. Edwards Lifesciences Corporation’s trailing 12-month revenue is $6.5 billion with a 15.4% net profit margin. Year-over-year quarterly sales growth most recently was 13.6%. Analysts expect adjusted earnings to reach $2.999 per share for the current fiscal year. Edwards Lifesciences Corporation does not currently pay a dividend.

As of September 1, 2026, Agilent Technologies, Inc. had a $42.3 billion market cap, putting it in the 92nd percentile of all stocks. Agilent Technologies, Inc.’s stock is up 11.3% in 2026, down 2.4% in the previous five trading days and up 19.31% in the past year.

Currently, Agilent Technologies, Inc.’s price-earnings ratio is 30.1. Agilent Technologies, Inc.’s trailing 12-month revenue is $7.2 billion with a 19.5% net profit margin. Year-over-year quarterly sales growth most recently was 10.0%. Analysts expect adjusted earnings to reach $6.202 per share for the current fiscal year. Agilent Technologies, Inc. currently has a 0.7% dividend yield.

How We Compare Edwards Lifesciences Corporation, Agilent Technologies and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Edwards Lifesciences Corporation, Agilent Technologies and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Edwards Lifesciences Corporation, Agilent Technologies and Inc.’s Quality Grades

Company	Ticker	Quality
Edwards Lifesciences Corporation	EW	A
Agilent Technologies, Inc.	A	A

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Edwards Lifesciences Corporation has a Quality Score of 89, which is Very Strong. Agilent Technologies, Inc. has a Quality Score of 92, which is Very Strong.

The Quality Grade Winner: It’s a Tie!

Looking at the Quality Grade breakdown above, both Edwards Lifesciences Corporation, Agilent Technologies and Inc. have a grade of A. For investors who focus solely on a company’s overall quality, you will need to conduct further research into both companies to see if they are a good fit for your portfolio. As a good rule of thumb, you should always analyze multiple factors based on a wide range of metrics before choosing a company to invest in.

Edwards Lifesciences Corporation, Agilent Technologies and Inc.’s Momentum Grades

Company	Ticker	Momentum
Edwards Lifesciences Corporation	EW	C
Agilent Technologies, Inc.	A	B

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Edwards Lifesciences Corporation has a Momentum Score of 50, which is Average. Agilent Technologies, Inc. has a Momentum Score of 61, which is Strong.

The Momentum Grade Winner: Agilent Technologies, Inc.

As you can clearly see from the Momentum Grade breakdown above, Agilent Technologies, Inc. is considered to have stronger momentum compared to Edwards Lifesciences Corporation. For those specifically looking for companies that have stronger momentum compared to other companies in the same industry, Agilent Technologies, Inc. could be a good stock to invest in. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Edwards Lifesciences Corporation, Agilent Technologies and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Edwards Lifesciences Corporation	EW	C
Agilent Technologies, Inc.	A	B

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Edwards Lifesciences Corporation has a Earnings Estimate Score of 59, which is Neutral. Agilent Technologies, Inc. has a Earnings Estimate Score of 80, which is Positive.

The Earnings Estimate Revisions Grade Winner: Agilent Technologies, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Agilent Technologies, Inc. has a better Earnings Estimate Revisions Grade than Edwards Lifesciences Corporation. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Agilent Technologies, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Edwards Lifesciences Corporation, Agilent Technologies and Inc. Grades

In addition to Quality, Momentum and Estimate Revisions, A+ Investor also provides grades for Value and Growth.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Edwards Lifesciences Corporation, Agilent Technologies and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Edwards Lifesciences Corporation, Agilent Technologies or Inc. Stock?

Overall, Edwards Lifesciences Corporation stock has a Momentum Score of 50, Estimate Revisions Score of 59 and Quality Score of 89.

Agilent Technologies, Inc. stock has a Momentum Score of 61, Estimate Revisions Score of 80 and Quality Score of 92.

Comparing Edwards Lifesciences Corporation, Agilent Technologies and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.